SK13352003A3 - Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases - Google Patents

Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases Download PDF

Info

Publication number
SK13352003A3
SK13352003A3 SK13352003A SK13352003A SK13352003A3 SK 13352003 A3 SK13352003 A3 SK 13352003A3 SK 13352003 A SK13352003 A SK 13352003A SK 13352003 A SK13352003 A SK 13352003A SK 13352003 A3 SK13352003 A3 SK 13352003A3
Authority
SK
Slovakia
Prior art keywords
acid
azithromycin
agents
use according
pharmaceutical compositions
Prior art date
Application number
SK13352003A
Other languages
English (en)
Slovak (sk)
Inventor
Ognjen Culic
Michael Parnham
Vesna Erakovic
Original Assignee
Pliva D D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva D D filed Critical Pliva D D
Publication of SK13352003A3 publication Critical patent/SK13352003A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
SK13352003A 2001-04-27 2002-04-10 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases SK13352003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20010301A HRP20010301A2 (en) 2001-04-27 2001-04-27 New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
PCT/EP2002/003984 WO2002087596A2 (en) 2001-04-27 2002-04-10 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases

Publications (1)

Publication Number Publication Date
SK13352003A3 true SK13352003A3 (en) 2004-10-05

Family

ID=10947306

Family Applications (1)

Application Number Title Priority Date Filing Date
SK13352003A SK13352003A3 (en) 2001-04-27 2002-04-10 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases

Country Status (19)

Country Link
US (1) US20050054587A1 (bg)
EP (1) EP1392327A2 (bg)
JP (1) JP2004531539A (bg)
CN (1) CN1582158A (bg)
AR (1) AR034223A1 (bg)
BG (1) BG108286A (bg)
BR (1) BR0209276A (bg)
CA (1) CA2443381A1 (bg)
CZ (1) CZ20032932A3 (bg)
EA (1) EA200301187A1 (bg)
HR (1) HRP20010301A2 (bg)
HU (1) HUP0303988A2 (bg)
IL (1) IL158236A0 (bg)
MX (1) MXPA03009849A (bg)
PL (1) PL364086A1 (bg)
SK (1) SK13352003A3 (bg)
WO (1) WO2002087596A2 (bg)
YU (1) YU84503A (bg)
ZA (1) ZA200308933B (bg)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB0315671D0 (en) 2003-07-04 2003-08-13 Chelsea And Westminster Nhs Tr Improvements in or relating to organic compounds
EP1699456A1 (en) * 2003-12-30 2006-09-13 Astellas Pharma Inc. Use of macrolides for treating or preventing airflow obstruction
WO2006115494A1 (en) * 2005-04-26 2006-11-02 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
EP1782816B1 (en) 2004-07-02 2011-10-19 Wakamoto Pharmaceutical Co., Ltd. Water-based medicinal composition containing azithromycin and method of preparing the same
JP2008526945A (ja) * 2005-01-14 2008-07-24 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 抗炎症活性を有する９ａ−カルバモイルおよびチオカルバモイルアザライド
US20060293261A1 (en) * 2005-06-24 2006-12-28 Taisho Pharmaceutical Co., Ltd. Clarithromycin or a salt thereof for the treatment or prevention of pulmonary disorders caused by the destruction of pulmonary alveoli
TW200817047A (en) * 2006-04-03 2008-04-16 Teva Pharma Drug microparticles
WO2007129646A1 (ja) 2006-05-01 2007-11-15 Taisho Pharmaceutical Co., Ltd. マクロライド誘導体
US7704959B2 (en) * 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
AU2009268372B2 (en) * 2008-07-10 2015-06-04 Inspire Pharmaceuticals, Inc. Method of treating blepharitis
WO2010062787A1 (en) 2008-11-03 2010-06-03 Washington University Bioluminescence imaging of myeloperoxidase activity in vivo, methods, compositions and apparatuses therefor
EP2393355A4 (en) * 2009-01-23 2012-07-25 Inspire Pharmaceuticals Inc METHOD FOR TREATING A DRY EYE WITH AZITHROMYCIN
EA201101139A1 (ru) 2009-01-30 2012-03-30 Глэксо Груп Лимитед Противовоспалительный макролид
US20130045939A1 (en) * 2010-03-19 2013-02-21 Catabasis Pharmaceuticals, Inc. Fatty acid macrolide derivatives and their uses
JP6460552B2 (ja) * 2015-07-14 2019-01-30 国立大学法人大阪大学 筋強直性ジストロフィー治療薬
CN113209084A (zh) * 2021-05-18 2021-08-06 南开大学 化合物cp0119在制备用于治疗炎性肠病的药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
EP0721324A1 (en) * 1993-10-01 1996-07-17 The Procter & Gamble Company Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
UA41995C2 (uk) * 1994-05-06 2001-10-15 Пфайзер Інк. Лікарська форма азитроміцину з контрольованим вивільненням ( варіанти ), спосіб її введення, спосіб її виготовлення і спосіб лікування інфекційних захворювань ссавців з її використанням ( варіанти )
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
KR100700475B1 (ko) * 1999-06-29 2007-03-28 바이오케미 에스.에이. 마크롤라이드
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin

Also Published As

Publication number Publication date
AR034223A1 (es) 2004-02-04
CN1582158A (zh) 2005-02-16
IL158236A0 (en) 2004-05-12
PL364086A1 (en) 2004-12-13
EA200301187A1 (ru) 2004-04-29
EP1392327A2 (en) 2004-03-03
CZ20032932A3 (cs) 2004-08-18
WO2002087596A3 (en) 2003-01-03
MXPA03009849A (es) 2004-05-24
JP2004531539A (ja) 2004-10-14
HRP20010301A2 (en) 2001-12-31
WO2002087596A2 (en) 2002-11-07
US20050054587A1 (en) 2005-03-10
HUP0303988A2 (hu) 2004-04-28
CA2443381A1 (en) 2002-11-07
ZA200308933B (en) 2004-11-17
BR0209276A (pt) 2004-06-15
YU84503A (sh) 2006-08-17
BG108286A (bg) 2004-09-30

Similar Documents

Publication Publication Date Title
SK13352003A3 (en) Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
Brown et al. Chronic ethanol ingestion and the risk of acute lung injury: a role for glutathione availability?
US6231894B1 (en) Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase
US20050245609A1 (en) Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
AU2002255805A1 (en) Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
WO2002003996A1 (en) Use of dammarane-type tritepenoid saporins
US20220265699A1 (en) Heparan sulfate (hs) oligosaccharides effect in liver ischemia reperfusion injury
CN111479574B (zh) 用于治疗和预防细胞外组蛋白介导的病理的化合物
US20230322837A1 (en) Preparation method for and application of class of stellate bifunctional compounds targeting spike protein against respiratory tract infection virus and salt thereof
KR101556812B1 (ko) 하부 요로 질환 치료제 및 하부 요로 증상 개선제
US8932587B2 (en) Methods of reducing or inhibiting toxic effects associated with a bacterial infection using alkaline phosphatase
EP2243474B1 (en) Protective effect of thymoquinone in sepsis
KR20200010164A (ko) 신규한 글루타미닐 고리화효소 억제제 및 다양한 질환의 치료에서의 이의 용도
KR100593393B1 (ko) 치료제
US20210038562A1 (en) Pharmaceutical composition for preventing or treating diabetes complications comprising novel chrysin derivative compound as active ingredient
AU2002312808A1 (en) Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
Cojocel et al. Renal ultrastructural and biochemical injuries induced by aminoglycosides.
EP1127574A1 (en) Use of chitinous materials for inhibiting cellular nitric oxide production
US5780513A (en) Method of inhibiting the release of bioactive IL-1
CN114366730B (zh) 没食子酸及包含其的药物组合物用于治疗细菌性前列腺炎的应用
KR100731870B1 (ko) 알러지성 질환 치료용 약학적 조성물
CA2662636A1 (en) N-acetylcysteine compositions and methods for treating acute exacerbations of inflammatory lung disease
KR101836641B1 (ko) C-메틸로테노이드계 화합물을 함유하는 혈관염증질환의 예방 또는 치료용 약학적 조성물
Zheng et al. Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation
CN112656793A (zh) 一种喹啉衍生物在制备治疗脓毒症药物中的应用

Legal Events

Date Code Title Description
FC9A Refused patent application